AstraZeneca PLC
1601.00
20-سبتمبر-24 10:24:57
15 متأخرة بدقائق
الأسهم
-4.00
-0.25%
نطاق اليوم
1594.50 - 1617.50
ISIN
N/A
المصدر
Cboe
-
Fusion (FUSN) Up 99% on $2.4B Buyout Offer From AstraZeneca
20 مارس 2024 13:32:29 بحسب NASDAQ Stocks
-
AstraZeneca To Buy Fusion Pharma For Up To $2.4 Bln
19 مارس 2024 02:31:51 بحسب NASDAQ US Markets
-
AstraZeneca To Expand Savings Programs For US Inhaled Respiratory Portfolio
18 مارس 2024 06:40:23 بحسب NASDAQ US Markets
-
First Week of AZN May 17th Options Trading
15 مارس 2024 11:39:15 بحسب NASDAQ Stocks
-
AstraZeneca To Buy Amolyt Pharma For Up To $1.05 Bln To Expand Late-stage Rare Disease Pipeline
14 مارس 2024 02:46:14 بحسب NASDAQ US Markets
-
AstraZeneca Announces Initiation Of Phase III Trial With BREZTRI
13 مارس 2024 06:41:44 بحسب NASDAQ US Markets
-
AZN Crosses Above Key Moving Average Level
11 مارس 2024 15:51:21 بحسب NASDAQ US Markets
-
AZN Crosses Above Key Moving Average Level
11 مارس 2024 15:44:19 بحسب NASDAQ Stocks
-
AstraZeneca's Datopotamab Deruxtecan Applications Validated In EU For Lung Cancer, Breast Cancer
04 مارس 2024 02:26:38 بحسب NASDAQ US Markets
-
AstraZeneca: Voydeya Recommended For Approval In The EU By CHMP - Quick Facts
26 فبراير 2024 01:56:02 بحسب NASDAQ US Markets
-
AstraZeneca Prices $5bln Four Tranche Notes Offering
22 فبراير 2024 02:24:41 بحسب NASDAQ US Markets
-
20 فبراير 2024 11:22:37 بحسب NASDAQ Stocks
-
20 فبراير 2024 11:17:15 بحسب NASDAQ US Markets
-
Ex-Dividend Reminder: Avista, ONE Gas and AstraZeneca
20 فبراير 2024 10:29:26 بحسب NASDAQ Stocks
-
Ex-Dividend Reminder: Avista, ONE Gas and AstraZeneca
20 فبراير 2024 10:25:27 بحسب NASDAQ US Markets
-
AstraZeneca's Tagrisso With Chemotherapy Approved In US To Treat Lung Cancer
19 فبراير 2024 03:46:28 بحسب NASDAQ US Markets
-
AstraZeneca Enters Oversold Territory
12 فبراير 2024 12:12:53 بحسب NASDAQ Stocks
-
NetDania - New 12 months Low: AstraZeneca PLC
12 فبراير 2024 02:15:03 بحسب NetDania Notify
-
AstraZeneca Plc (AZN) Q4 2023 Earnings Call Transcript
08 فبراير 2024 15:26:03 بحسب NASDAQ US Markets
-
Ionis Says Eplontersen Got Fast Track Status To Treat Transthyretin-mediated Amyloid Cardiomyopathy
08 فبراير 2024 07:43:49 بحسب NASDAQ US Markets